Announcement of the Company's Board of Directors resolved
to convene the 2022 Annual General Shareholders' Meeting
Date of events
2022/03/25
To which item it meets
paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/25
2.General shareholders' meeting date:2022/06/29
3.General shareholders' meeting location:
Conference room on 23F, No. 168, Jingguo Road, Taoyuan
District, Taoyuan City
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)2021 Business report
(2)2021 Auditing Committee Review Report
(3)2021 Distributable Compensation for Employees and
Directors
6.Cause for convening the meeting II.Acknowledged matters:
(1)Adoption of the 2021 Business Report,
Financial Statement and Combined Financial Statement.
(2)Adoption of the Proposal for Distribution of 2021
Profits.
7.Cause for convening the meeting III.Matters for Discussion:
(1)Amendment to the Rules of Procedures for
Shareholders'meetings
(2)Amendment to the Regulations Governing
the Acquisition and Disposal of Assets
8.Cause for convening the meeting IV.Election matters:None
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/05/01
12.Book closure ending date:2022/06/29
13.Any other matters that need to be specified:
(1)Period of time that accepts Shareholders'
Proposals:2022/04/24 to 2022/05/04
(2)Site that accepts Shareholders' Proposals:
168 Jingguo Road, 19F, Taoyuan City,District
Attachments
Original Link
Original Document
Permalink
Disclaimer
ShareHope Medicine Co. Ltd. published this content on 25 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2022 06:15:18 UTC.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.